Research Topics
Species | Henriette J ScherpbierSummaryAffiliation: Academic Medical Center Country: The Netherlands Publications
| Collaborators
|
Detail Information
Publications
Liver failure in a child receiving highly active antiretroviral therapy and voriconazoleHenriette J Scherpbier
Emma Children s Hospital, Academic Medical Centre, Amsterdam, The Netherlands
Clin Infect Dis 37:828-30. 2003..We describe a 10-year-old child with vertically transmitted acquired immunodeficiency syndrome who was receiving antiretroviral combination therapy and died of liver failure after beginning voriconazole therapy...- Long-term experience with combination antiretroviral therapy that contains nelfinavir for up to 7 years in a pediatric cohortHenriette J Scherpbier
Emma Children s Hospital, Academic Medical Center, Amsterdam, The Netherlands
Pediatrics 117:e528-36. 2006..We sought to provide long-term data on the clinical, immunologic, and virologic response to highly active antiretroviral therapy in infants and children who are naive to protease inhibitors... - Once-daily highly active antiretroviral therapy for HIV-infected children: safety and efficacy of an efavirenz-containing regimenHenriette J Scherpbier
Emma Children s Hospital, Academic Medical Center, Meibergdreef 9, 1105 AZ Amsterdam, The Netherlands
Pediatrics 119:e705-15. 2007.... - A pharmacokinetic and pharmacogenetic study of efavirenz in children: dosing guidelines can result in subtherapeutic concentrationsRob ter Heine
Department of Pharmacy and Pharmacology, Slotervaart Hospital, Amsterdam, The Netherlands
Antivir Ther 13:779-87. 2008..Our main objectives were to study the population pharmacokinetics of efavirenz and to explore the adequacy of dosing guidelines... - Population pharmacokinetics and pharmacodynamics of nelfinavir and its active metabolite M8 in HIV-1-infected childrenKristel M L Crommentuyn
Department of Pharmacy and Pharmacology, Slotervaart Hospital, Amsterdam, The Netherlands
Pediatr Infect Dis J 25:538-43. 2006.... - Viral dynamics after starting first-line HAART in HIV-1-infected childrenVincent Bekker
Emma Children s Hospital, Academic Medical Center, The Netherlands
AIDS 20:517-23. 2006..Therefore viral decay and time to reach a pVL of < 400 copies/ml during the first weeks after starting HAART were studied in a cohort of HIV-1-infected children... - The pharmacokinetics of nelfinavir in HIV-1-infected childrenRolf P G van Heeswijk
Dept of Pharmacy and Pharmacology, Slotervaart Hospital, Amsterdam, The Netherlands
Ther Drug Monit 24:487-91. 2002..However, due to a large interpatient variability in the exposure, individual dosage adjustments based on plasma concentrations may be necessary for both dosing regimens to ensure optimal treatment... - Haematological parameters of HIV-1-uninfected infants born to HIV-1-infected mothersMadeleine J Bunders
Department of Paediatric Haematology, Immunology and Infectious Diseases, Emma Children s Hospital, Academic Medical Centre, University of Amsterdam, Amsterdam, The Netherlands
Acta Paediatr 94:1571-7. 2005..To investigate haematological parameters in infants born to HIV-1-infected mothers and exposed to combination antiretroviral therapy (ART) used to prevent mother-to-child transmission (MTCT)... 
Mannose-binding lectin and the risk of HIV transmission and disease progression in children: a systematic reviewJoël Israëls
Department of Pediatric Immunology, Hematology and Infectiology, Emma Children s Hospital, Academic Medical Centre, H7 228, Meibergdreef 9, 1105 AZ Amsterdam, The Netherlands
Pediatr Infect Dis J 31:1272-8. 2012..It is unclear whether genetically determined MBL deficiency is related to vertical HIV transmission and disease progression in HIV-infected children...